Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
Di Nisio M, Potere N, Candeloro M, Spacone A, Pieramati L, Ferrandu G, Rizzo G, La Vella M, Di Carlo S, Cibelli D, Parruti G, Levi M, Porreca E.
Di Nisio M, et al. Among authors: porreca e.
Eur J Intern Med. 2021 Jan;83:34-38. doi: 10.1016/j.ejim.2020.10.020. Epub 2020 Nov 3.
Eur J Intern Med. 2021.
PMID: 33162299
Free PMC article.